HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaijin Xu Selected Research

Kaijin Xu Research Topics

Disease

19Infections
05/2024 - 07/2009
18COVID-19
01/2022 - 01/2020
7Tuberculosis (Tuberculoses)
08/2023 - 09/2013
5Hepatitis B
01/2021 - 11/2015
3Inflammation (Inflammations)
10/2022 - 01/2021
3Fever (Fevers)
01/2022 - 01/2018
3Severe Acute Respiratory Syndrome
01/2021 - 06/2020
3Cytokine Release Syndrome
01/2021 - 01/2020
3Communicable Diseases (Infectious Diseases)
01/2018 - 07/2009
2Dysbiosis
01/2022 - 01/2022
2Hepatitis
01/2021 - 01/2021
2Virus Diseases (Viral Diseases)
01/2021 - 11/2015
2Liver Diseases (Liver Disease)
01/2021 - 01/2021
2Chronic Hepatitis B
01/2021 - 05/2015
2Critical Illness (Critically Ill)
12/2020 - 01/2020
2Hypertension (High Blood Pressure)
12/2020 - 01/2020
2Coinfection
11/2020 - 01/2020
2Pneumonia (Pneumonitis)
05/2020 - 12/2012
2Bacterial Infections (Bacterial Infection)
10/2015 - 12/2012
2Meningitis
01/2011 - 04/2010
1Meningoencephalitis
08/2023
1Pulmonary Tuberculosis
07/2023
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2023
1Zoonoses
01/2023
1Leptospirosis
01/2023
1Extensively Drug-Resistant Tuberculosis
12/2022
1Leukemia
10/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Neoplasms (Cancer)
01/2022
1Hematoma
01/2022
1Chemical and Drug Induced Liver Injury
01/2022
1Ulcer
01/2022
1False Aneurysm (Pseudoaneurysm)
01/2022
1Black hairy tongue
01/2022
1Adenocarcinoma of Lung
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Coronavirus Infections
01/2021

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
12/2022 - 01/2020
5Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 10/2012
5Viral RNAIBA
01/2022 - 01/2020
5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 01/2013
4AcidsIBA
02/2021 - 01/2020
3Nucleic AcidsIBA
01/2021 - 05/2020
3Anti-Infective Agents (Microbicides)IBA
01/2017 - 07/2009
2AntigensIBA
12/2022 - 09/2013
2Interleukin-18 (Interleukin 18)IBA
10/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
2Antiviral Agents (Antivirals)IBA
02/2021 - 01/2020
2LopinavirFDA Link
01/2021 - 01/2020
2Alanine Transaminase (SGPT)IBA
01/2021 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 12/2020
2Ritonavir (Norvir)FDA Link
01/2021 - 01/2020
2ProcalcitoninIBA
01/2021 - 01/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020 - 01/2020
2PolymersIBA
01/2017 - 10/2015
2Peptides (Polypeptides)IBA
12/2012 - 07/2009
2Antimicrobial Cationic PeptidesIBA
01/2011 - 04/2010
1ImipenemFDA Link
05/2024
1relebactamIBA
05/2024
1omadacyclineIBA
05/2024
1Type III Secretion SystemsIBA
12/2023
1contezolidIBA
08/2023
1fropenem (faropenem)IBA
07/2023
1Tetracycline (Achromycin)FDA LinkGeneric
01/2023
1Penicillins (Penicillin)FDA Link
01/2023
1Pattern Recognition ReceptorsIBA
12/2022
1Drug CombinationsIBA
12/2022
1EpiregulinIBA
10/2022
1AmphiregulinIBA
10/2022
1Small Cytoplasmic RNAIBA
01/2022
1cobicistat mixture with darunavirIBA
01/2022
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022
1Volatile Fatty AcidsIBA
01/2022
1SteroidsIBA
01/2022
1Linezolid (Zyvox)FDA Link
01/2022
1baloxavirIBA
02/2021
1favipiravirIBA
02/2021
1Serine (L-Serine)FDA Link
01/2021
1Butyric Acid (Butanoic Acid)IBA
01/2021
1Oxalic Acid (Disodium Oxalate)IBA
01/2021
1Succinic Acid (Succinate)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1CholesterolIBA
01/2021
14-deoxythreonic acidIBA
01/2021
1phosphoric acid (orthophosphoric acid)FDA Link
01/2021
12-hydroxybutyric acidIBA
01/2021
1Oleic Acid (Oleate)IBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
12-palmitoylglycerolIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1Hepatitis B e AntigensIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1ChemokinesIBA
01/2021
1C-Reactive ProteinIBA
01/2021

Therapy/Procedure

12Therapeutics
01/2022 - 04/2010
4Artificial Liver (Bioartificial Liver)
01/2021 - 01/2020
2Aftercare (After-Treatment)
01/2022 - 01/2021
2Artificial Respiration (Mechanical Ventilation)
01/2020 - 01/2020
1Stents
01/2022